Citation Impact
Citing Papers
2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
2018 Standout
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
Effect of Clopidogrel Added to Aspirin in Patients with Atrial Fibrillation
2009 Standout
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
Management of Antithrombotic Therapy in Atrial Fibrillation Patients Presenting with Acute Coronary Syndrome and/or Undergoing Percutaneous Coronary Intervention/ Stenting
2009
Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial
2016
A Novel User-Friendly Score (HAS-BLED) To Assess 1-Year Risk of Major Bleeding in Patients With Atrial Fibrillation
2010 Standout
Reversing Dabigatran in Life-Threatening Bleeding Occurring During Cardiac Ablation With Factor Eight Inhibitor Bypassing Activity
2013
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation
2015
Novel Anticoagulants for Stroke Prevention in Atrial Fibrillation
2010
Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
2009 Standout
The aortic root in supravalvular aortic stenosis: The potential surgical relevance of morphologic findings
1997
Surgical management of congenital obstruction of the left main coronary artery with supravalvular aortic stenosis
2000
Therapeutic applications of compounds in the Magnolia family
2011 Standout
Reducing Unnecessary Right Ventricular Pacing with the Managed Ventricular Pacing Mode in Patients with Sinus Node Disease and AV Block
2006
Cellular pathophysiology of ischemic acute kidney injury
2011 Standout
A New Paradigm for Physiologic Ventricular Pacing
2006
Recommendations from the Heart Rhythm Society Task Force on Device Performance Policies and Guidelines
2006
Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events
2009 Standout
The REDCap consortium: Building an international community of software platform partners
2019 Standout
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study
2011 Standout
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Efficacy and safety of direct oral anticoagulants in patients undergoing cardioversion for atrial fibrillation: A systematic review and meta-analysis of the literature
2015
Cardioversion and Risk of Adverse Events with Dabigatran versus Warfarin—A Nationwide Cohort Study
2015
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
2013 Standout
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
2008
Antithrombotic Therapy for VTE Disease
2012 Standout
GRADE guidelines: 3. Rating the quality of evidence
2011 Standout
A randomized comparison ofatrial and dual-chamber pacing in177 consecutive patients with sick sinus syndrome
2003
Outcomes After Cardioversion and Atrial Fibrillation Ablation in Patients Treated With Rivaroxaban and Warfarin in the ROCKET AF Trial
2013
Thromboembolic Complications After Cardioversion of Acute Atrial Fibrillation
2013
Williams–Beuren Syndrome
2010 Standout
ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices—Summary Article
2002
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
2009 Standout
Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations
2018 Standout
Natural history of supravalvular aortic stenosis and pulmonary artery stenosis
1990
Pacemaker implantation and quality of life in the Mode Selection Trial (MOST)
2006
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary
2008
Congenital supravalvar aortic stenosis: a simple lesion?
2001
ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Summary Article
2002
Primary and Secondary Prevention of Cardiovascular Disease
2012
Prospective Randomized Study of Mode Switching in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction
2004
Future directions of stroke prevention in atrial fibrillation: the potential impact of novel anticoagulants and stroke risk stratification
2010
Glocal Clinical Registries: Pacemaker Registry Design and Implementation for Global and Local Integration – Methodology and Case Study
2013
European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation
2013
Percent right ventricular pacing predicts outcomes in the DAVID trial
2005
Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment
2008
Obstruction to Left Coronary Artery Blood Flow Secondary to Obliteration of the Coronary Ostium in Supravalvular Aortic Stenosis
1988
Predictable and Less Predictable Unwanted Cardiac Drugs Effects: Individual Pre‐Disposition and Transient Precipitating Factors
2010
Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation
2014
Obstructive sleep apnoea and its cardiovascular consequences
2008 Standout
The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency
2003
Antithrombotic Therapy for Atrial Fibrillation
2012
Minimizing Ventricular Pacing to Reduce Atrial Fibrillation in Sinus-Node Disease
2007
Antithrombotic Therapy in Atrial Fibrillation
2008
Biventricular Pacing for Atrioventricular Block and Systolic Dysfunction
2013
Novel oral anticoagulants in a real-world cohort of patients undergoing catheter ablation of atrial fibrillation
2013
Atrial Overdrive Pacing in Patients with Sleep Apnea with Implanted Pacemaker
2005
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Canadian Trial of Physiological Pacing
2004
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Adverse Effect of Ventricular Pacing on Heart Failure and Atrial Fibrillation Among Patients With Normal Baseline QRS Duration in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction
2003
Is Dual-Chamber Programming Inferior to Single-Chamber Programming in an Implantable Cardioverter-Defibrillator?
2006
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2019 Standout
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial
2018
Panic disorder and cardiovascular/cerebrovascular problems: results from a community survey
1990
Long-Term Outcomes After Catheter Ablation of Cavo-Tricuspid Isthmus Dependent Atrial Flutter
2009
Systematic Review and Adjusted Indirect Comparison Meta-Analysis of Oral Anticoagulants in Atrial Fibrillation
2012
Guidelines for the Primary Prevention of Stroke
2014 Standout
The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes
2006
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons
2019 Standout
ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: Executive Summary
2008 Standout
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Correction: Glocal Clinical Registries: Pacemaker Registry Design and Implementation for Global and Local Integration – Methodology and Case Study
2013
Impact of Psychological Factors on the Pathogenesis of Cardiovascular Disease and Implications for Therapy
1999 Standout
Contemporary Definitions and Classification of the Cardiomyopathies
2006 Standout
Worldwide Epidemiology of Atrial Fibrillation
2013 Standout
Sex, age, and time to cardioversion. Risk factors for cardioversion of acute atrial fibrillation from the FinCV study
2016
Heart Failure During Cardiac Pacing
2006
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Atrial High Rate Episodes Detected by Pacemaker Diagnostics Predict Death and Stroke
2003
Using Dabigatran in Patients With Stroke
2011
Systematic review and network meta-analysis comparing antithrombotic agents for the prevention of stroke and major bleeding in patients with atrial fibrillation
2014
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation—Executive Summary
2006
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2006
An Updated Definition of Stroke for the 21st Century
2013 Standout
Cost-Effectiveness of Dual-Chamber Pacing Compared With Ventricular Pacing for Sinus Node Dysfunction
2005
Left ventricular function during and after right ventricular pacing
2004
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Prevention of Ventricular Desynchronization by Permanent Para-Hisian Pacing After Atrioventricular Node Ablation in Chronic Atrial Fibrillation
2006
2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2012
Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS2 Score: A Subgroup Analysis of the RE-LY Trial
2011
Cardiovascular Outcomes With Atrial-Based Pacing Compared With Ventricular Pacing
2006
Works of Greg Flaker being referenced
The Mode Selection Trial (MOST) in sinus node dysfunction: Design, rationale, and baseline characteristics of the first 1000 patients
2000
Digoxin and Mortality in Patients With Atrial Fibrillation
2018
Success rate of catheter ablation in atrial flutter: Comparison of a 4- or 5-mm tip electrode catheter with an 8-mm tip electrode catheter
2006
Efficacy and Safety of Apixaban in Patients After Cardioversion for Atrial Fibrillation
2013
Ventricular Pacing or Dual-Chamber Pacing for Sinus-Node Dysfunction
2002
Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk
2008
Panic Disorder, Cardiology Patients, and Atypical Chest Pain
1988
Dabigatran Versus Warfarin in Patients With Atrial Fibrillation
2011
Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures
2014
Supravalvular aortic stenosis
1983